A recently published study by FMI expects the global thrombocytopenia treatment market to augment at a 5.2% CAGR from 2023 to 2033. By the end of the said assessment period, a valuation of US$ 10 Billion is expected for the market. The thrombocytopenia treatment market is predicted to increase significantly, since patients with thrombocytopenia experience …
Author Archives: Editor AN
Global Marburg Virus Disease Therapeutics Market to surge at a 5.5% CAGR until 2033, reaching US$ 155 Million | FMI Report
During the forecast period 2023 to 2033, the Marburg virus disease therapeutics market is expected to grow at a value of 5.5% CAGR, according to Future Market Insights. By the year 2033, the global market for Marburg virus disease therapeutics is expected to rise up to a market valuation of US$ 155 Million. Growth of …
Oral segment constitutes the bulk of 45% in the Babesiosis Treatment Market in 2023, FMI Report
In 2023, the market for babesiosis treatments is projected to be worth US$1.21 billion. The overall market for babesiosis treatment is anticipated to grow at a CAGR of 5.0% between 2023 and 2033, reaching a value of approximately US$ 1.98 Billion by 2033 due to ongoing advancements in pharmaceuticals and biotechnology for the treatment of …
Aarskog Scott syndrome treatment Market Expected to Register 6.5% CAGR in the forecast period 2023 to 2033 | FMI Study
During the forecast period 2023 to 2033, the Aarskog Scott syndrome treatment market is expected to grow at a value of 6.5% CAGR, according to Future Market Insights. By the year 2033, the global market for Aarskog Scott syndrome treatment is expected to rise up to a market valuation of US$ 6 Billion. Ongoing clinical …
The Global Coxsackeivirus Infections Treatment Market Is Expected to Register Growth at 8.2% CAGR through 2033 | FMI Study
The global coxsackievirus infections treatment market is currently valued at US$ 5.5 Billion in 2023 and is anticipated to expand at a CAGR of 8.2%. Owing to the technological advances in healthcare the market is likely to propel to US$ 12.1 Billion by 2033. Major factors driving the global coxsackievirus diagnostics market are increase in incidence of coxsackievirus …
Donohue Syndrome Treatment Market to reach US$ 25 Billion by 2033, growing at a 4% CAGR | FMI Report
A recently published study by FMI expects the global Donohue syndrome treatment market to augment at a 4% CAGR from 2023 to 2033. By the end of the said assessment period, a valuation of US$ 25 Billion is expected for the market. The Donohue syndrome treatment market is expected to grow during the forecast period …
With unstoppable Occurrences of Chronic Ailments, the global Cell and Gene Therapy Manufacturing Market to reach US$240 Billion by 2033 at a Robust CAGR of 29% from 2023 to 2033
The global cell and gene therapy manufacturing market is worth US$ 19.3 Billion as of now and expected to reach US$ 240 Billion by the year 2033 at a staggering CAGR of 29% between 2023 and 2033. The changing landscape of treating chronic ailments through advanced therapies is the key factor driving the cell and …
Mediation To Possess 43% Market Share for Congenital Adrenal Hyperplasia Treatment Market | FMI Study
During the forecast period 2023 to 2033, the Congenital Adrenal Hyperplasia treatment market is expected to grow at a value of 8.1% CAGR, according to Future Market Insights. By the year 2033, the global market for Congenital Adrenal Hyperplasia treatment is expected to rise up to a market valuation of US$ 892 Million. Growth of …
Self-Ligating Brackets Market Growth Accelerating with Rising Importance of Dental Cosmetic Procedures | Future Market Insights
As per Future Market Insights’ latest industry analysis, the valuation for the global self-ligating brackets market was around US$ 355.4 Million in 2022 and is projected to exhibit growth at a CAGR of 6.6% over the forecast period, to reach an estimated valuation of US$ 717.1 Million in 2033. The consumer demands dental services for …
Global MGUS Management Market to surpass US$ 53 million by 2033; expanding at a 7% CAGR: FMI Report
The global monoclonal gammopathy of undetermined significance (MGUS) management market is expected to garner a market value of US$ 27 million in 2023 and is expected to accumulate a market value of US$ 53.11 million by registering a CAGR of 7% in the forecast period 2023 to 2033. The market for Monoclonal Gammopathy of Undetermined …